Related Experiment Video
Updated: Aug 4, 2025

Measuring Bacterial Load and Immune Responses in Mice Infected with Listeria monocytogenes
Published on: August 9, 2011
Adjunctive dexamethasone treatment in adults with listeria monocytogenes meningitis: a prospective nationwide cohort
Matthijs C Brouwer1, Diederik van de Beek1
1Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
Background:
A French cohort study described a detrimental effect of adjunctive dexamethasone treatment in listeria meningitis. Based on these results guidelines recommend not to use dexamethasone if L. monocytogenes is suspected or stop dexamethasone when the pathogen is detected. We studied clinical characteristics, treatment regimens and outcome of adults with Listeria monocytogenes meningitis in a nationwide cohort study on bacterial meningitis.
Methods:
We prospectively assessed adults with community-acquired L. monocytogenes meningitis in the Netherlands between Jan 1, 2006, and July 1, 2022. We identified independent predictors for an unfavourable outcome (Glasgow Outcome Scale score 1 to 4) and mortality by logistic regression.
Findings:
162 out of 2664 episodes (6%) of community-acquired bacterial meningitis episode were caused by L. monocytogenes in 162 patients. Adjunctive dexamethasone 10 mg QID was started with the first dose of antibiotics in 93 of 161 patients (58%) and continued for the full four days in 83 (52%) patients. Different doses, duration or timing of dexamethasone were recorded in 11 patients (7%) and 57 patients (35%) did not receive dexamethasone. The case fatality rate was 51 of 162 (31%) and an unfavourable outcome occurred in 91 of 162 patients (56%). Age and the standard regimen of adjunctive dexamethasone were independent predictors for an unfavourable outcome and mortality. The adjusted odds ratio of dexamethasone treatment for unfavourable outcome was 0.40 (95% confidence interval 0.19-0.81).
Interpretation:
Adjunctive dexamethasone is associated with an improved outcome in patients with L. monocytogenes meningitis and should not be withheld if L. monocytogenes is suspected or detected as causative pathogen.
Funding:
European Research Council and Netherlands Organisation for Health Research and Development.
Insights
Dexamethasone may improve outcomes for Listeria monocytogenes meningitis, contrary to previous guidelines. This study found dexamethasone treatment was linked to better results and lower mortality in patients with this specific bacterial meningitis.
Area of Science:
- Infectious Diseases
- Neurology
- Clinical Medicine
Background:
- Previous French cohort studies suggested dexamethasone is detrimental in Listeria meningitis, leading to guidelines against its use.
- Current guidelines recommend against using dexamethasone if Listeria monocytogenes is suspected or to discontinue it upon detection.
Purpose of the Study:
- To investigate the clinical characteristics, treatment regimens, and outcomes of adults with Listeria monocytogenes meningitis.
- To evaluate the effect of adjunctive dexamethasone on outcomes in a nationwide cohort of bacterial meningitis patients.
Main Methods:
- A prospective nationwide cohort study in the Netherlands from January 1, 2006, to July 1, 2022.
- Assessed 162 adults with community-acquired Listeria monocytogenes meningitis.
- Used logistic regression to identify predictors of unfavorable outcome (Glasgow Outcome Scale 1-4) and mortality.
Main Results:
- Listeria monocytogenes caused 6% of 2664 bacterial meningitis episodes.
- Adjunctive dexamethasone was administered to 58% of patients.
- Dexamethasone treatment was independently associated with a significantly improved outcome (adjusted OR 0.40; 95% CI 0.19-0.81) and reduced mortality.
Conclusions:
- Adjunctive dexamethasone is associated with improved outcomes in Listeria monocytogenes meningitis.
- Dexamethasone should not be withheld when Listeria monocytogenes is suspected or confirmed.
- Findings challenge existing guidelines regarding dexamethasone use in Listeria meningitis.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Tonsillitis II: Management
Antimicrobial Effectiveness
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Acute Pyelonephritis II: Diagnostic Studies and Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

